Aims and scope

We will soon be and expanding the scope of the journal Hormones and Cancer to become Discover Oncology: a new, fully open access general oncology journal that aims to provide a unified forum for researchers and clinicians. 

The journal spans basic and translational science, through to preclinical, clinical, and epidemiology, and welcomes content interfacing at all levels of cancer research.

Discover Oncology will include, but is not limited to, cancer causation and the underlying biology of disease, the molecular interactions between genes, hormones, the immune system and the metabolism, screening and prevention, diagnosis and treatment, prognostication, novel therapeutic agents and clinical trials. All cancer types, including benign tumours, will be considered for publication.

The journal will shortly be open for submissions and will publish its first articles in January 2021.

• We welcome research from across all fields relevant to oncology.

• Our streamlined submission process ensures a swift turnaround time to publish your research rapidly while maintaining the highest peer-review standards.

• As a fully open access journal, we ensure that your research highly discoverable and instantly available globally to everyone.

• We provide you with an excellent support service at every stage to guide you through the whole submission, review and publication process.

• The Discover journals uphold the ethical standards for research and publication as defined by COPE, and support authors in adhering to these throughout the peer-review process.

If you have any questions about Discover Oncology, please contact Rosie Ainscough-Daniel (rosie.daniel@springer.com)